SCYNEXIS
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCYNEXIS and other ETFs, options, and stocks.About SCYX
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J.
SCYX Key Statistics
Stock Snapshot
The current SCYNEXIS(SCYX) stock price is $0.93, with a market capitalization of 41.5M. The stock trades at a price-to-earnings (P/E) ratio of -6.75.
On 2026-03-23, SCYNEXIS(SCYX) stock traded between a low of $0.88 and a high of $0.94. Shares are currently priced at $0.93, which is +5.5% above the low and -0.9% below the high.
The SCYNEXIS(SCYX)'s current trading volume is 266.07K, compared to an average daily volume of 296.57K.
In the last year, SCYNEXIS(SCYX) shares hit a 52-week high of $1.31 and a 52-week low of $0.57.
In the last year, SCYNEXIS(SCYX) shares hit a 52-week high of $1.31 and a 52-week low of $0.57.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.